Breaking News

Pall Purchases Technology License For Biopharm Application

Acoustic wave separation technology was bought from FloDesign Sonics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pall Corporation has signed an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications. The AWS technology enables very-high-efficiency continuous removal of the cells in a closed system without centrifugation, thereby streamlining a challenging step in the biologics manufacturing process within a small operating footprint. The technology will complement Pall’s STA...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters